The main objective of this study was to unravel the distribution of different Pfcrt genotypes in the central, littoral, eastern and southern regions of Cameroon and also in locations bordering Gabon and Equatorial Guinea. This is because (i) the chloroquine-resistant malaria parasite Plasmodium falciparum shows a wide occurrence in Cameroon, (ii) mutations in the 72nd to 76th amino acid positions of the Pfcrt gene are known to confer resistance to chloroquine, and (iii) only a single chloroquine-resistant haplotype (C 72 V 73 I 74 E 75 T 76 ) has so far been reported in Cameroon.
Introduction
The evolution and spread of the chloroquine-resistant malarial parasite Plasmodium falciparum have posed a great challenge to malaria-control efforts in all countries where malaria is endemic. Although chloroquine has been banned from national malaria-control programmes in many countries with endemic malaria, it still continues to be used unofficially in many countries, including Africa, because of its high efficacy, easy availability and affordability. 1 -4 Furthermore, in countries with endemic malaria such as India and south-east Asia where the malarial parasites Plasmodium vivax and P. falciparum co-occur, and due to the susceptibility of the former to chloroquine, this drug is still used to treat uncomplicated P. vivax malaria. Thus, continuous drug pressure exerted by chloroquine usage has possibly helped in the emergence of new varieties of chloroquine-resistant P. falciparum isolates in these epidemiological settings that have thereafter spread to other countries with endemic malaria that have previously been dominated by chloroquine-susceptible isolates.
African countries are known to be mostly populated with chloroquine-resistant P. falciparum isolates imported either from south-east Asia via India or from South America. 5 Such historical migrations have been traced with population genetics analysis based on the differential distribution of chloroquine-resistant Pfcrt haplotypes, formed by a differential arrangement of amino acid sequences from the 72nd to the 76th positions of the Pfcrt polypeptide chain. It is well known that these haplotypes are genetically associated with chloroquine resistance; while C 72 V 73 M 74 N 75 K 76 is considered to be wild-type (susceptible), two chloroquine-resistant mother haplotypes (C 72 V 73 I 74 E 75 T 76 and S 72 V 73 M 74 N 75 T 76 ) have given rise to an array of other haplotypes following different mutational steps. 5 The SVMNT haplotype-bearing P. falciparum isolates are known to be generally fitter in the chloroquine environment than the CVIET-bearing parasites. Furthermore, the chloroquineresistant (CVIET) types can be reversed to wild-type (chloroquine susceptible) with treatment with the chloroquine-reversing agent verapamil, while those bearing SVMNT haplotypes cannot. 6, 7 Furthermore, the SVMNT haplotypes can be differentiated into two different genetic types based on the nucleotide sequence arrangements-S (agt) VMNTand S (tct) VMNT-and these have different evolutionary histories. While the S (agt) VMNT type has been reported to have originated in Papua New Guinea, the S (tct) VMNT has a South American origin. 6, 7 Malaria due to P. falciparum is highly endemic in Cameroon, with several reports of chloroquine-resistant isolates in the field. 2, 8, 9 Genotyping of the 72nd to 76th amino acid positions of the Pfcrt gene is the best way to determine the molecular and genetic epidemiology of chloroquine-resistant malaria, and previous studies have indicated that, in Cameroon, the chloroquine-resistant malaria parasites are categorized mostly into the CVIET type. 4 Considering the high migration potentiality of malarial parasites, with the recent entry of chloroquine-resistant P. falciparum to many African countries, 5 we hypothesize that Cameroon, which is considered to be 'Africa in miniature' for malaria (H. G. Ngassa Mbenda, G. Awasthi, P. K. Singh, I. Gouada and A. Das, unpublished results), could also have been populated with chloroquine-resistant parasites with different Pfcrt genetic backgrounds. We therefore conducted a largescale molecular epidemiological study with highly sensitive DNA sequencing of the Pfcrt gene in 180 P. falciparum parasites collected in the southern, eastern, littoral and central regions of Cameroon and also in locations bordering Gabon and Equatorial Guinea in order to describe the distributional patterns of different chloroquineresistant Pfcrt haplotypes in Cameroon.
Methods
We used a PCR-based diagnostic assay 10, 11 to identify P. falciparum monoinfections following DNA isolation from finger-prick blood samples. (Figure 1 ) covering almost all of the southern area (the most malarious region) of Cameroon were used in the present study. To determine the amino acid sequences of the Pfcrt polypeptide chain, the entire second exon of the Pfcrt gene was PCR-amplified using published primers 12 
Each DNA fragment was sequenced in both directions (2×coverage) and the products were run in an ABI 3730xl DNA Analyzer (in-house facilities at the National Institute of Malaria Research). The DNA sequences were assembled and edited using the SeqMan and EditSeq computer programs (DNAStar, Madison, USA), respectively. All 180 sequences were aligned using the MegAlign computer program (DNAStar, Madison) and scanned for single nucleotide polymorphisms (SNPs) present in the 72nd to 76th amino acid positions to define different Pfcrt haplotypes. The study was approved by the Ethics Committee of Cameroon (No003/CNE/SE/2012) and written informed consent was obtained from all adult patients and the guardians of the minor patients participating in the study. (Figure 1 ). In total, 65 isolates (36%) were of CVMNK type-meaning that about one-third of P. falciparum isolates are still susceptible to chloroquine in Cameroon. Out of the remaining 115 P. falciparum isolates bearing the chloroquine-resistant Pfcrt genotype, a major proportion (87%) was of CVIET type, corroborating previous observations in Cameroon. 4 The remaining 13% of P. falciparum isolates bearing chloroquine-resistant Pfcrt genotypes were segregated into five different haplotypes (SVMNT, 5.2%; SVMET, 1.7%; CVMDT, 3.5%; CVMET, 0.9%; and CVMNT, 1.7%) (Figure 1) . Notably, in previous studies, 2,4,13 none of these five haplotypes was reported in Cameroon.
Results and discussion
Out of the five locations in Cameroon, samples from Douala were found to bear all seven Pfcrt haplotypes including CVMNK (Figure 1 ), representing the highest haplotype diversity of the Pfcrt gene. However, in Douala, the CVMNK haplotype was present in a fairly low proportion (27.4%) in comparison with the four other locations. The SVMNT haplotype, which is considered to be the fittest one in a chloroquine environment in comparison with other haplotypes, 6, 14 was found only in Douala. Since our dataset is based on DNA sequencing, we were able to further determine the nucleotide composition of the SVMNT haplotype. Interestingly, all six parasite isolates bearing the SVMNT haplotypes were found to be of S (agt) VMNT type. So far, only one African country (Tanzania) has reported the presence of P. falciparum isolates bearing the S (agt) VMNT haplotype. 15 In addition, the other four chloroquine-resistant Pfcrt haplotypes found in Douala were found to be distributed in comparatively higher frequencies than in the four other Cameroonian locations.
The results indicating a high haplotype diversity of the chloroquine-resistant Pfcrt gene essentially mean that the Pfcrt gene governing chloroquine resistance in P. falciparum is under massive genetic reconstruction in Cameroon, as has been proposed for India. 16 Such genetic reformation might have been propelled by (i) selection pressure exerted by a misuse of chloroquine in the field 16 and/or (ii) pressure exerted by amodiaquine, an antimalarial that is part of WHO-recommended artemisinin combined therapy for the treatment of uncomplicated P. falciparum malaria in Cameroon. The second contention is justified by the fact that amodiaquine has a very similar genetic target (Pfcrt) to chloroquine. 4, 14 Although the S (agt) VMNT haplotype was found only in Douala, and considering its higher fitness property and the fact that Douala is a cosmopolitan city in Cameroon, it could spread to other parts fairly quickly.
Whatever the case may be, observations on the high haplotype diversity of the chloroquine-resistant Pfcrt haplotypes coupled with the appearance of the S (agt) VMNT type is daunting and could pose a greater challenge than before to Cameroon's malaria control programme. This is true since it has been predicted from previous studies 14 that the continued use of amodiaquine in combination therapies is hazardous in regions where P. falciparum isolates bearing the SVMNT haplotype occur. Similar large-scale DNA sequencing-based surveys of the Pfcrt gene in other parts of Cameroon and in other African countries would help not only in unravelling the extent of the diversity of different chloroquineresistant Pfcrt haplotypes, but also in choosing appropriate chemotherapeutic combinations for the treatment of malaria in Africa.
